119 related articles for article (PubMed ID: 38147302)
1. Hepatitis B surface antigen seroclearance is uncommon but durable in the long run.
Yip TC; Brunetto MR
Hepatology; 2024 Jun; 79(6):1258-1260. PubMed ID: 38147302
[No Abstract] [Full Text] [Related]
2. Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability.
Seto WK; Cheung KS; Wong DK; Huang FY; Fung J; Liu KS; Lai CL; Yuen MF
J Gastroenterol; 2016 May; 51(5):487-95. PubMed ID: 26446756
[TBL] [Abstract][Full Text] [Related]
3. Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels.
Tseng TC; Chiang C; Liu CJ; Hong CM; Su TH; Yang HC; Yang WT; Liu CH; Chen PJ; Kao JH
Gastroenterology; 2023 Apr; 164(4):669-679.e6. PubMed ID: 36642151
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance.
Taniguchi H; Iwasaki Y; Aimi M; Shimazaki G; Moriya A
JGH Open; 2020 Aug; 4(4):698-706. PubMed ID: 32782959
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance.
Fung J; Cheung KS; Wong DK; Mak LY; To WP; Seto WK; Lai CL; Yuen MF
Hepatology; 2018 Aug; 68(2):462-472. PubMed ID: 29534307
[TBL] [Abstract][Full Text] [Related]
6. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus.
Boyd A; Gozlan J; Miailhes P; Lascoux-Combe C; Cam MS; Rougier H; Zoulim F; Girard PM; Lacombe K
AIDS; 2015 Sep; 29(15):1963-73. PubMed ID: 26153669
[TBL] [Abstract][Full Text] [Related]
7. Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co-infected Chinese.
Yang R; Gui X; Ke H; Xiong Y; Gao S
J Viral Hepat; 2020 Feb; 27(2):127-134. PubMed ID: 31571343
[TBL] [Abstract][Full Text] [Related]
8. Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B.
Hui KY; Fung J; Cheung KS; Mak LY; Seto WK; Yuen MF
Gut Liver; 2023 Mar; 17(2):280-287. PubMed ID: 36317514
[TBL] [Abstract][Full Text] [Related]
9. Hepatic flares promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance: A long-term follow-up study.
Nagaoka S; Abiru S; Komori A; Sasaki R; Bekki S; Hashimoto S; Saeki A; Yamasaki K; Migita K; Nakamura M; Ezaki H; Yatsuhashi H
Hepatol Res; 2016 Mar; 46(3):E89-99. PubMed ID: 25951079
[TBL] [Abstract][Full Text] [Related]
10. Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta-analysis.
Song A; Wang X; Lu J; Jin Y; Ma L; Hu Z; Zheng Y; Shen C; Chen X
J Viral Hepat; 2021 Apr; 28(4):601-612. PubMed ID: 33455067
[TBL] [Abstract][Full Text] [Related]
11. Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance.
Lee HW; Lee JI; Kim S; Kim S; Chang HY; Lee KS
BMC Gastroenterol; 2020 Apr; 20(1):113. PubMed ID: 32305059
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B surface antigen seroclearance: Relationship to hepatitis B e-antigen seroclearance and hepatitis B e-antigen-negative hepatitis.
Fung J; Wong DK; Seto WK; Kopaniszen M; Lai CL; Yuen MF
Am J Gastroenterol; 2014 Nov; 109(11):1764-70. PubMed ID: 25244963
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-122 levels are important predictor of hepatitis B virus surface antigen seroclearance.
Akuta N; Suzuki F; Kobayashi M; Hosaka T; Fujiyama S; Kawamura Y; Sezaki H; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
J Med Virol; 2018 Oct; 90(10):1586-1592. PubMed ID: 29896794
[TBL] [Abstract][Full Text] [Related]
14. Potential of ultra-highly sensitive immunoassays for hepatitis B surface and core-related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Suzuki F; Hosaka T; Imaizumi M; Kobayashi M; Ohue C; Suzuki Y; Fujiyama S; Kawamura Y; Sezaki H; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Hepatol Res; 2021 Apr; 51(4):426-435. PubMed ID: 33270344
[TBL] [Abstract][Full Text] [Related]
15. A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.
Seto WK; Wong DK; Fung J; Hung IF; Fong DY; Yuen JC; Tong T; Lai CL; Yuen MF
Hepatology; 2012 Sep; 56(3):812-9. PubMed ID: 22422518
[TBL] [Abstract][Full Text] [Related]
16. Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.
Arai M; Togo S; Kanda T; Fujiwara K; Imazeki F; Yokosuka O
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):414-8. PubMed ID: 22273987
[TBL] [Abstract][Full Text] [Related]
17. Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.
Lee HL; Jang JW; Han JW; Lee SW; Bae SH; Choi JY; Han NI; Yoon SK; Kim HJ; Lee S; Cho SG; Min CK; Kim DW; Lee JW
Dig Dis Sci; 2019 Oct; 64(10):2992-3000. PubMed ID: 30982209
[TBL] [Abstract][Full Text] [Related]
18. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
Yeh ML; Hung CH; Huang JF; Liu CJ; Lee CM; Dai CY; Wang JH; Lin ZY; Lu SN; Hu TH; Yu ML; Kao JH; Chuang WL; Chen PJ; Chen DS
PLoS One; 2011; 6(6):e20752. PubMed ID: 21695152
[TBL] [Abstract][Full Text] [Related]
20. Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China.
He Y; Lin W; Li H; Gu F; Zhong H; Lan Y; Li Y; Guo P; Hu F; Cai W; Tang X; Li L
Chin Med J (Engl); 2023 Nov; 136(22):2686-2693. PubMed ID: 37881959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
